HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

Beyond the Map

Learn more about the Hepatitis B and Hepatitis C epidemics in the United States.

View Local Data

Learn more about Hepatitis C where you live with state-specific statistics and national and regional comparison charts.

Deeper Look: Opioids

Take a deeper look at how the ongoing opioid crisis impacts the Hepatitis C epidemic in the U.S.

Hepatitis ABCs

Know the difference between Hepatitis A, B, and C? Learn the facts, symptoms, and who’s at risk for each disease here.

View the Map

HepVu News & Updates

Stay up to date with new data, maps, infographics, blog posts, and other educational resources to help you better understand the Hepatitis B and Hepatitis C epidemics in the United States and their intersection with the opioid epidemic.

View News & Updates
HIVPlan-General_3-800x800

News & Updates

Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025

According to the U.S. Department of Health and Human Services (HHS), there are an estimated 2.4 million people living with Hepatitis C, approximately 850,000 to 2.2 million people living with Hepatitis B, and more than 30 states have been affected by Hepatitis A outbreaks in the United States.

Learn More
Carolyn-Wester_hires

Vu Q&A

HepVu Q&A: Dr. Carolyn Wester on CDC’s Division of Viral Hepatitis 2025 Strategic Plan

HepVu spoke with Dr. Wester on the goals and objectives of CDC’s Division of Viral Hepatitis 2025 Strategic Plan.

Learn More
Kushner_Tatyana_Headshot

Vu Q&A

Dr. Tatyana Kushner on Trends in Hepatitis B Among Women of Childbearing Age

Tatyana Kushner, Founder of the Women's Liver Clinic at Mount Sinai Hospital and Assistant Professor of Medicine, speaks to her latest findings regarding trends in Hepatitis B immunity and infections in women of childbearing age. 

Learn More
pNROzfFy-384x368

Infographics

COVID-19 & Viral Hepatitis Care

In collaboration with the National Viral Hepatitis Roundtable (NVHR), the Hepatitis Education Project (HEP), NASTAD, Hep B United, and Hepatitis B Foundation, HepVu deployed a survey to measure the impact of the COVID-19 pandemic on viral hepatitis, and the experiences of clinical providers, community-based organizations, and health departments during COVID-19.

Learn More
VHLC-General_2-800x800

News & Updates

Liver Cancer and Viral Hepatitis

From 2008 to 2017, there has been a 20% increase in liver cancer rates in the U.S. One of the most common risk factors for liver cancer worldwide is chronic viral hepatitis. Click to read more.

Learn More
Beste_Lauren _cropped photo

Vu Q&A

Dr. Lauren Beste on Hepatitis C, Liver Cancer, and Veterans’ Health

HepVu spoke with Dr. Lauren Beste about the intersections of Hepatitis C, liver cancer, and Veterans’ health.

Learn More
Head Shot

News & Updates

What’s New in Viral Hepatitis – October 2020

Dr. Valdiserri reviews significant articles on prevention, public health, and policy advances in viral hepatitis. This month, he highlights Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States, authored by Kushner T, Chen Z, Tressler S, Kaufman H, Feinberg J, Terrault NA, and published in Clinical Infectious Diseases in August 2020.

Learn More
Thaddeus-Pham-e1481133172943

Vu Q&A

Thaddeus Pham on Hawaii’s Viral Hepatitis Elimination Strategy

After releasing Hep Free Hawaii’s strategic plan to eliminate viral hepatitis, Thaddeus Pham spoke with HepVu to unpack Hawaii’s multifaceted approach to eliminate Hepatitis A, B, and C by 2030.

Learn More
01-HepVu-AAIRAD_v2-800x800

Vu Q&A

Vu Q&A: Chari Cohen and Chioma Nnaji on HIV and Viral Hepatitis in the African Immigrant Community

For African Immigrant and Refugee HIV and Hepatitis Awareness Day, Vu spoke with Chari Cohen and Chioma Nnaji about the challenges of addressing the needs of immigrant and refugee communities with targeted and culturally sensitive public health measures.

Learn More

Research Brief

What's New in Viral Hepatitis – August 2020

HepVu Co-Chair Dr. Valdiserri summarizes an MMWR publication on the age distribution of acute and chronic Hepatitis C and its connection to the new Hepatitis C testing guidelines.

Learn More
c72Hh7md_400x400

Vu Q&A

HepVu Q&A: Tyler Bartholomew on the Impact of COVID-19 on SSP’s Hepatitis C and HIV Screening

Tyler Bartholomew, Director of Research and Evaluation at IDEA Exchange and a PhD candidate at the University of Miami, outlines how the IDEA Exchange and SSPs across the country are responding to the COVID-19 pandemic.

Learn More
01-HepVu-WorldHepDay_v3-800x800

Awareness Day

World Hepatitis Day 2020

On July 28, HepVu recognizes World Hepatitis Day as an opportunity to raise awareness of the burden of viral hepatitis and educate everyone on the need for prevention, testing, and care.

Learn More
Su Wang

Vu Q&A

HepVu Q&A: Dr. Su Wang on the State of Global Hepatitis Elimination During COVID-19

Dr. Su Wang, President of the World Hepatitis Alliance and is the Medical Director of the Center for Asian Health at Saint Barnabas Medical Center, spoke with HepVu about World Hepatitis Day.

Learn More
Kate Moraras

Vu Q&A

Vu Q&A: Kate Moraras on the Need for Universal Hepatitis B Screenings

Kate Moraras, Deputy Director of Public Health at the Hepatitis B Foundation and the Director of Hep B United, spoke with HepVu about Hepatitis B screening and the recently released USPSTF draft recommendation.

Learn More

Sign up for HepVu updates: